• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMC3838C100TU
Medical Device Problem Codes Difficult to Insert (1316); Difficult To Position (1467)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Perforation of Vessels (2135)
Date of Event 03/27/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
A valiant captivia stent graft system was planned to be implanted in a patient to treat a 67 mm thoracic abdominal aortic aneurysm.The patient was being treated for a thoracic co-abdominal repair with another investigational device.It was reported that the valiant stent graft system was inserted through the right common femoral artery but would not pass through the right external iliac artery.The diameter of the right external iliac artery was 6 mm.The physician then used sequential dilators to dilate the eternal iliac artery.While removing the dilators, the patient's blood pressure dropped and the external iliac artery ruptured and emergency treatment was started.A balloon was inflated in the distal aorta to occlude the artery and an angiogram was taken to see the extent of the rupture.An endurant ii limb was then deployed into the right common iliac artery down to the right common femoral to cover the injury.However, the injury was too extensive, and the physician then cut down on the common femoral site and reteroperitoneal to assess the injury and clamped off the bleeding artery.A 10mm graft was used to bypass the right common iliac artery down to the right common femoral artery.The bleeding was controlled and the patient left the operating room in a stable condition.It was also reported that the endurant ii limb was explanted during the procedure.It was reported that the procedure was subsequently completed s uccessfully approximately 8 days post the index procedure.The physician reported that the cause of the event was anatomy related and that the right external iliac (6mm) was too small for the valiant captivia device.No additional clinical sequelae were reported, and the patient is being monitored.
 
Additional Manufacturer Narrative
Film evaluation summary: the exact cause of the valiant positioning difficulties and resulting external iliac rupture could not be determined from the pre-implant films provided.Images during implant were not available for review and the reported events could not be assessed.Pre-implant ct¿s and 3d-ct film report confirmed that the common iliac arteries were non-tortuous and mildly calcified.The right common iliac ranged in diameter from 14 ¿ 11 ¿ 10mm, and both the right and left external iliacs measured 6mm in diameter with no appreciable calcification.It is possible that implanting via the small right external iliac artery may have contributed to the events.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - CW
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7453464
Report Number2953200-2018-00583
Device Sequence Number806710
Product Code MIH
UDI-Device Identifier00643169347168
UDI-Public00643169347168
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/06/2019
Device Model NumberVAMC3838C100TU
Device Catalogue NumberVAMC3838C100TU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/28/2018
Initial Date Received by Manufacturer 03/27/2018
Supplement Date Received by Manufacturer05/07/2018
Initial Report FDA Received Date04/24/2018
Supplement Report FDA Received Date05/29/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
-
-